Central Institute Of Mental Health, Mannheim
Clinical trials sponsored by Central Institute Of Mental Health, Mannheim, explained in plain language.
-
Shock therapy maintenance may keep schizophrenia at bay
Disease control Recruiting nowThis study looks at whether maintenance electroconvulsive therapy (ECT) can help people with schizophrenia that doesn't get better with the strongest medication, clozapine. About 140 adults who improved after a course of ECT will either continue with regular ECT sessions or recei…
Phase: NA • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Disease control
Last updated May 26, 2026 09:51 UTC
-
Brain training shows promise for borderline personality disorder
Symptom relief Recruiting nowThis study tests a brain-training technique called neurofeedback for people with borderline personality disorder (BPD) who struggle with intense, unstable emotions. The goal is to see if learning to calm a specific brain area (the amygdala) can reduce emotional ups and downs. 164…
Phase: PHASE1, PHASE2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Symptom relief
Last updated May 26, 2026 09:58 UTC
-
CBD boosts Anti-Craving drug in alcohol addiction trial
Symptom relief Recruiting nowThis study tests whether adding cannabidiol (CBD) to the standard medication naltrexone can better reduce alcohol cravings in people with alcohol addiction. About 150 adults who experience strong cravings will receive either a high dose of CBD plus naltrexone, a lower dose of CBD…
Phase: PHASE2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Symptom relief
Last updated May 26, 2026 09:35 UTC